Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients. Farmeconomia. Health Economics and Therapeutic Pathways, [S. l.], v. 15, n. 1S, p. 5–14, 2014. DOI: 10.7175/fe.v15i1s.973. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/973. Acesso em: 28 dec. 2025.